Xenotransplant volume will quickly exceed the capacity of medical centers. Specialized xenotransplant centers near urban cores can achieve efficiencies not possible at a general hospital.
These xenotransplant destinations will treat patients for the perioperative period f a short hospital stay followed by routine outpatient care until the xenograft recipient stabilizes.
These independent centers can absorb improved genetics or technologies from any developer insulating them from future changes.
Inefficiency in allotransplantation is driven by idle time imposed by the uncertainty of donor availability. This inefficiency can be eliminated when organ availability is controlled.
Initially xenotransplantation will be developed at existing transplant groups with limited expansion capabilities.
Developing special purpose xenotransplant hospitals will improve efficiency and allow for the capture of sizable revenue outside of the companies designing and developing new animals.
These centers would be regional near population centers that are used for the xenotransplant event and yearly follow-ups and associated with dedicated manufacturing resources.
The campus would serve as a destination with associated lodging and food service for the patient and their families during the perioperative period where increased monitoring is needed and then for subsequent follow-ups.
Integrating an efficient xenograft center will help to defray the added costs involved with producing the organ.